Signal Sequence Receptor, beta (Translocon-Associated Protein Beta) (SSR2) (C-Term) Peptide
-
- Target See all SSR2 products
- SSR2 (Signal Sequence Receptor, beta (Translocon-Associated Protein Beta) (SSR2))
- Protein Region
- C-Term
- Origin
- Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- KAGYFNFTSA TITYLAQEDG PVVIGSTSAP GQGGILAQRE FDRRFSPHFL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ssr2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SSR2 (Signal Sequence Receptor, beta (Translocon-Associated Protein Beta) (SSR2))
- Background
-
TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins.
Alias Symbols: 1500032E05Rik, AI315033, AU020133, TLAP, TRAPB, TRAPbeta
Protein Size: 183 - Molecular Weight
- 20 kDa
- Gene ID
- 66256
- NCBI Accession
- NM_025448, NP_079724
- UniProt
- Q9CPW5
-